Interestingly, the GSK3β inhibitor lithium was found to be effective against ceramide-induced apoptosis via the inhibition of PP2A activity, suggesting that drugs targeting different components of the ceramide signaling pathway could be promising therapeutic agents for AD. The gene discussed is GSK3B; the disease is Alzheimer disease.